Neuroleptic-induced deficit syndrome: old problem,new challenge

Abstract

Keywords

neuroleptic side effects deficit syndrome

Get full access to this article

View all access options for this article.

References

Anonymous (1992) Facing up to the problem of non-compliance in schizophrenia. Curr Ther 33: 69-72

Baldessarini R.J. (1985) Drugs and the treatment of psychiatric disorders . In Goodman Gilman A , Goodman L S , Rall T , Murad F (eds) The pharmacological basis of therapeutics 7th edn. Macmillan Publishing Company, New York, pp. 387-445

Carpenter W.T. , Heinrichs D.W. , Alphs L.D. (1985) Treatment of negative symptoms. Schizophrenia Bull 11: 440-452

Emerick D.F. , Sanberg P.R. (1991) Neuroleptic dysphoria. Biol Psychiatr 29: 201-203

Harrow M. , Fichter C.G. , Grossman L.S. , Yonan C.A. , Sands J. (1991) Neuroleptic depression in schizophrenia. Biol Psychiatr 30: 844-848

Hogan T.P. , Awad A.G. , Eastwood M.R. (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13: 177-183

Hogan T.P. , Awad A.G. , Eastwood M.R. (1985) Early subjective response and prediction of outcome to neuroleptic drug therapy in schizophrenia. Can J Psychiatr 30: 246-248

Hollister LE (1992) Neuroleptic dysphoria: so what's new? Biol Psychiatr 31: 531-537

Nelson A. (1975) Drug default among schizophrenic patients. Am J Hosp Pharm 32: 1237-1242

10.

Sandell B. , Eriksson L. (1992) Patient experience with remoxipride—results contributed by patients in group meetings and individual interviews. Presented at the XVIII CINP Congress, Nice , June 1992

11.

Van Putten T. , May P R A , Marder S.R. (1984) Response to antipsychotic medication: the doctor's and the consumer's view. Am J Psychiatr 141: 16-19